ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0015793;glycerol transport;7.0;1.0;0.8509193652572005;9.628524252492122;38.31975435487899;7.9853141584524145;0.0012825276927178712;0.7592887026755414;[AQP9, AQP1]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[SPARC, PLXND1, SERPINE1, CXCL13, ETS1, AQP1, CDH5, C3AR1, PROK2, CYP1B1, HOXA5, PPP1R16B, GHSR, SEMA6A, PRKCB, CYBB, HSPG2, SFRP2, COL4A2, HGS, ADAM12, AGTR1, EPHA2, C5AR1, TWIST1, C3, HMOX1, PLCG1, TGFB2, JUP, PLK2, TNFSF12, CXCL10, IL6, ID1, NRP1, ECM1, CD40, ITGB2, TNFAIP3, FASLG, ADM, PRL, BRCA1, PIK3C2A, HHEX, STAB1, CTSH, ITGB8, EMILIN1, CD34, CCR3, CCR2, IL10, ANXA1, ANXA3, GAB1, EMP2, SIRT1, F3, DCN, GREM1, IL1A, CEACAM1, IL1B, CHI3L1, ENG, CX3CR1, SP100, PTGS2, THBS2, DLL1, THBS1, GPNMB, CXCR2, E2F2, SEMA4A, STAT1, TIE1, KLF4, SULF1, PML, LRG1, TEK, PF4]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[ARRB2, ABHD12, CHL1, SLITRK6, DRD4, SCN1A, SNCA, TMOD1, NR4A2, CXCL12, FOXA2]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0002237;response to molecule of bacterial origin;4.0;0.6873818243518346;0.5936909121759173;8.741221057491218;31.746667436368902;4.018171853803189;0.0010625323889495053;0.45548949546759565;[IL1RN, SPARC, GFI1, SERPINE1, ICAM1, EDNRB, JUNB, MEF2C, SLC11A1, SLPI, TRIB1, ABCB4, MGST1, KLRK1, PLCG2, S100A14, CD14, ELANE, ABCA1, JUN, FZD5, PPBP, CD27, CD24, CD40, ADM, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, EDN1, ARG1, RIPK2, PDCD1LG2, FOS, TLR1, IL1B, RARA, TLR6, TLR4, TLR2, PTGER2, PTGS2, IL12RB2, GCH1, CCL20, NR1H2, IL10RA, CARD9, NR1H4, LILRB1, LILRB2, PF4, CD86, CSF3, CD80, CXCL13, MPO, LOXL1, PYCARD, GHSR, CD96, CD180, F2R, KMO, ADAM9, S100A8, CD274, C5AR1, LY96, CSF2RB, TNFRSF11A, STAP1, NLRP3, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, PTGIR, CHUK, PDE4D, IRAK3, TNFRSF1B, DCN, LTA, IRF8, CX3CR1, CEBPB, HDAC2, CEBPE, NOD2, CNR1, CCL2, SNCA, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, FCGR2B]
GO:0048489;synaptic vesicle transport;7.0;0.7671156992804218;0.7344772148974115;9.292052015870908;108.01043080855717;5.459585514144159;0.003615011916085639;0.6301228223472235;[LIN7A, SNCA, SYT2, DNM2, SYNJ1]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[NLGN4Y, NLGN1, SYT2, KIAA1109, SYNJ1, SNCA]
GO:0018153;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;9.0;1.0;0.896240625180289;9.628524252492122;470.89138909934985;9.083926447120524;0.015760311018418835;0.8607930461318132;[TGM2]
GO:2001205;negative regulation of osteoclast development;10.0;1.0;0.9152410118609203;9.628524252492122;1250.359070569308;8.16763571524637;0.041848392841848644;0.8329342821725234;[LILRB1, LTF, FBN1]
GO:2000117;negative regulation of cysteine-type endopeptidase activity;11.0;0.8259837884571596;0.845420846558242;9.538912093802434;565.4444864912041;5.076593261888053;0.018924918095861203;0.6920461678283469;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, LTF, BIRC3, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, CCR3, IL10, PPP1R16B, GHSR, MED1, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, HTRA1, TGFA, TWIST1, NOD2, IQGAP3, NRAS, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0031115;negative regulation of microtubule polymerization;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;405.4514152206468;7.292166977892469;0.013570093984851534;0.7881627702307852;[STMN1, SNCA]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNG2, KCNE3, KCNE4, SLC1A3, KCNA5, AQP1, KCNMB3, KCNN3, KCNH1, SLC12A2, KCNH2, KCND2, SLC12A1, KCNIP4, KCNJ15, KCNJ16, ATP1B2, ATP1B1, KCNQ1, FXYD2]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0045415;negative regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[BCL3, KLF4, ELANE]
GO:2000009;negative regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;7.212124270218933;0.0024696432832320894;0.7197477358342742;[NEDD4L, GOPC]
GO:0001956;positive regulation of neurotransmitter secretion;8.0;0.7508913569872202;0.7504456784936101;9.33127272902419;367.30173324646773;7.069023426578259;0.012293258461660482;0.7365101867784198;[NLGN1, KMO, SNCA]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, KCNH2, CAMK2D, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0001959;regulation of cytokine-mediated signaling pathway;6.0;0.6108066114563391;0.628523618318314;8.112176763124033;55.1119710577094;4.759793790865545;0.0018445480737477274;0.5665363884080561;[IL1RN, GFI1, TNF, PYCARD, MED1, IL1R1, IL1R2, PADI2, TXK, STAP1, CAV1, IL6, PTPRC, CD24, ECM1, TNFAIP3, TREM2, EDN1, CHUK, SYK, ARG1, IFNGR1, RIPK2, IFNGR2, IRAK3, TRAF1, PARP9, MMP12, IFNG, PXDN, IRF7, BIRC2, BIRC3, USP18, CCL5, CD74, STAT1, NR1H2, NR1H4, F2RL1, PTPN6]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:1903421;regulation of synaptic vesicle recycling;6.0;0.7671156992804218;0.7066781622303554;9.176539128749065;29.360544556841745;6.943860283624253;9.826710035429039E-4;0.6782296504172152;[CYFIP1, NLGN1, LRRK2, SNCA]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:1903426;regulation of reactive oxygen species biosynthetic process;6.0;0.7866048967936545;0.7164227609869718;9.223059144383958;42.429949999716015;5.514393750639154;0.0014200922420146414;0.6051266654433651;[ITGB2, TNF, CLU, ICAM1, AKT1, CD36, CD34, IL10, EDN1, DNM2, IFNG, IL1B, TLR6, TLR4, PTGS2, SLC30A10, AIF1, KLRK1, SNCA, AGXT2, CAV1, KLF4, PTX3]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[TNF, PYCARD, CYP1B1, PRKCD, MSH6, MELK, MSH2, LGALS12, EPHA2, CUL5, TP53BP2, HMOX1, SFN, TNFRSF10B, JMY, BCL3, BCL2, CD24, BCL2L1, CDKN1A, BRCA1, BRCA2, GPX1, TNFRSF1B, SIRT1, PPP1R15A, CEBPB, BCL2A1, PERP, E2F1, E2F2, MLH1, POU4F1, PML]
GO:1900159;positive regulation of bone mineralization involved in bone maturation;8.0;1.0;0.875;9.628524252492122;331.3384553333554;9.777073627680469;0.011089599914757432;0.875;[LTF]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, ICAM1, LGALS1, MYB, AKT1, TNFSF11, ICOSLG, PRKCE, HLA-G, HLA-E, SFRP2, CCDC80, IL23A, NINJ1, COL8A1, PRKCQ, HHLA2, EBI3, GATA3, CD1D, THY1, PRKCZ, EPB41L5, KLRK1, NCKAP1L, ICOS, ELANE, LYN, EGR3, JUP, TNFSF14, FN1, AZU1, VNN1, CD28, CD27, CD24, NRP1, CD3E, EPB41L4B, CTLA4, CCR7, CD36, JAK3, CCR2, HLA-DPA1, HAVCR2, IL10, ANXA1, SYK, RIPK2, IL18, EMP2, PDCD1LG2, VAV1, CEACAM6, IL1B, RARA, PTAFR, AIF1, PAK1, HLA-DMB, PDPN, FLNA, CCL19, IL12RB1, CD74, CCL21, LILRB1, LILRB2, LILRB4, CD40LG, HLA-DPB1, FOXA2, CD86, CD83, CD80, SIRPG, IHH, CXCL13, TNF, ETS1, PYCARD, GRAP2, SIRPA, MAP3K8, IL6R, TGM2, TPM1, OLFM4, ADAM9, ADAM8, CARD11, CD274, BLM, NID1, CORO1A, RASGRP1, DPP4, BTLA, NLRP3, TGFB2, TGFB1, VCAM1, CAV1, IL6, CXCL12, PTPRC, NR4A3, CDK6, BCL6, IL7R, NFKBID, DOCK5, SIRPB1, CYR61, TNFSF13B, DUSP10, EMILIN2, EMILIN1, ITGA4, DNM2, ZAP70, IFNG, MMRN1, LCK, XCL1, NOD2, HSPD1, HLX, CCL5, CCL2, FYN, CSK, CD4, CD6, CD5, DNAJA3, PTPN6, TEK]
GO:0071280;cellular response to copper ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.518977089658987;0.0026274528238337297;0.6565011041187423;[AQP1, SNCA]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CEBPA, CEBPB, IFITM1, CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, FAM20C, LTF]
GO:0048814;regulation of dendrite morphogenesis;10.0;0.8259837884571596;0.8282329060895002;9.533214072687796;153.5143611256957;5.334422371190153;0.0051379875129217364;0.6880436199995941;[NLGN1, LRRK2, SDC2, FMR1, NEDD4L, RAB21, YWHAH, NEDD4, ID1, SHANK3]
GO:1905606;regulation of presynapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.485423408851448;80.99250311658214;8.390779266560578;0.0027107461907915228;0.7800242071602487;[NLGN1, SNCA]
GO:0046878;positive regulation of saliva secretion;7.0;1.0;0.8509193652572005;9.628524252492122;141.10840522306705;8.67846133901236;0.004722771333496198;0.7947362817240173;[AQP1]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC8A1, SCN1A, SLC13A1, SLC38A1, SLC6A16, SLC6A15, SLC6A13, SLC6A12, ATP1B2, ATP1B1, SLC5A7, SGK1, CAPS2, SLC22A4, SLC24A2, SLC24A1, SLC24A4, NEDD4L, SLC38A11, SLC5A10, SLC5A4, SLC38A6, SLC17A6, SLC17A1, SCN3A, SLC17A3, SLC12A2, SLC10A2, SLC12A1, SLC4A7, SLC6A6, FXYD2]
GO:0072488;ammonium transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.193206181234276;79.759283350777;7.069023426578259;0.002669471435055758;0.7124295520356204;[SLC22A4, SLC12A2, SLC22A2, RHAG, RHCE, AQP1]
GO:0001921;positive regulation of receptor recycling;6.0;1.0;0.8231203125901445;9.628524252492122;202.5973984952176;7.138016298065211;0.006780752601813882;0.6881587980249038;[ARAP1, SNCA]
GO:0000160;phosphorelay signal transduction system;6.0;0.8436909121759173;0.7449657686781032;9.271849308553389;26.42836680105094;7.697632086000634;8.845336528452411E-4;0.7167775754447168;[KCNH2, KCNH1]
GO:0097623;potassium ion export across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;138.27080336829306;8.390779266560578;0.0046277993530927835;0.8615337942327104;[KCNH2, KCNQ1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, CDK6, NDUFS4]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0035378;carbon dioxide transmembrane transport;7.0;1.0;0.8509193652572005;9.628524252492122;75.4531771037942;8.67846133901236;0.0025253499342132637;0.7947362817240173;[RHAG, AQP1]
GO:0015886;heme transport;5.0;0.8436909121759173;0.712086467948879;9.310070521373587;55.35916853657787;7.57984905034425;0.0018528215509021678;0.6778748447945537;[ABCB6, ABCG2]
GO:0035377;transepithelial water transport;6.0;1.0;0.8231203125901445;9.628524252492122;37.816033014382604;9.083926447120524;0.0012656685927712316;0.7876727335416686;[CFTR, AQP1]
GO:0032780;negative regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.329885291612335;7.004484905440688;0.0017179650668126642;0.6813299963962409;[PLN, LTF]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, HTRA1, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, ADAM8, TIMP1, LCP1, A2M, ELANE]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[POSTN, EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:1901017;negative regulation of potassium ion transmembrane transporter activity;10.0;0.7866048967936545;0.8085434602577476;9.418803721510052;728.707892328508;7.004484905440688;0.024389197361709854;0.7734506956670166;[KCNE3, CAV1, NEDD4L]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[MED1, ARID4A, BPGM, GATA1, BCL6, NCKAP1L, RHAG]
GO:0007006;mitochondrial membrane organization;5.0;0.6763753087927167;0.6284286662572787;8.578702127993445;39.09948622157772;4.981283082083729;0.0013086246165831567;0.5449840603320351;[CHCHD3, YWHAH, ATP5J2, TFDP1, ATP5J, ATP5I, ATP5H, ATP5O, ATP5L, TP53BP2, E2F1, SFN, SNCA, GZMB, BCL2, BCL2L1]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0002227;innate immune response in mucosa;5.0;1.0;0.7902410118609202;9.628524252492122;46.05095502005584;6.832634648514029;0.0015412840213524692;0.639662265535933;[DEFA4, HIST1H2BK, RNASE3, DEFA1, CAMP, LTF]
GO:0072112;glomerular visceral epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;72.77032193269073;7.8311634786251565;0.002435557186049328;0.7514054297404357;[BASP1, CD24]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0032410;negative regulation of transporter activity;6.0;0.6324783794010864;0.6393595022906877;8.124446855715847;47.261139029285694;5.433268205826786;0.0015817877910464942;0.6009779013089371;[, CAMK2D, KCNE3, FMR1, TWIST1, NEDD4L, PLN, EPHB2, DRD4, SNCA, NDFIP2, GPR35, CAV1, PRKCE, MMP9, GEM, NEDD4, FKBP1B, GOPC, CALM3]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PDE4D, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;188.1075192762445;7.212124270218933;0.006295789384399518;0.7197477358342742;[PTGIR, MYOCD, LRP1, HGS, SNCA]
GO:1903285;positive regulation of hydrogen peroxide catabolic process;8.0;1.0;0.875;9.628524252492122;565.2094731881521;9.083926447120524;0.01891705241210629;0.839552420951524;[SNCA]
GO:1903284;positive regulation of glutathione peroxidase activity;7.0;1.0;0.8509193652572005;9.628524252492122;224.73580921301883;9.777073627680469;0.0075217052852625714;0.8509193652572005;[SNCA]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, RIPK2, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, NCF1, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, GREM1, CD24]
GO:0006883;cellular sodium ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;285.76071857591336;6.8867018697843045;0.009564154082785858;0.7484268790654467;[C7, NEDD4L, ATP1B2, ATP1B1, SLC8A1]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2, SNCA]
GO:0003254;regulation of membrane depolarization;6.0;0.7248374789738407;0.6855390520770648;8.992535485772125;38.60784531422591;6.015873511986907;0.0012921698378621823;0.6307723637598831;[CAMK2D, LRRK2, IFI6, NEDD4L, DCN, BCL2]
GO:0006644;phospholipid metabolic process;5.0;0.5326392268888578;0.5565606253053492;7.595602726447178;99.62941633188608;3.7463883674192062;0.003334506903974791;0.4818314871956144;[SLA2, EREG, BTC, PLBD1, PDGFA, PIK3R3, PLA2G7, PIK3R5, CD19, INPP5D, PLCG2, PIP5K1B, PLCG1, ICOS, CD28, SLC44A5, ACHE, SLC44A1, IMPA1, IMPA2, GAB1, VAV1, PLSCR1, KIT, PLCB1, HBEGF, SGMS1, PNPLA8, KITLG, LPCAT2, NDUFAB1, PNPLA6, CD86, CD80, FGF5, ABHD12, PDGFRB, PDGFRA, CISH, TTC7B, CSF1R, SOCS2, RARRES3, SRD5A3, BMX, SYNJ1, SERINC5, PLEK, PIK3CD, PIK3C2A, LCK, PIK3C3, AGPAT3, FYN, SNCA, TRAT1, EGF, MBOAT7, MBOAT2, PIKFYVE]
GO:0060445;branching involved in salivary gland morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;38.2921993719795;7.474488534686424;0.0012816054522381;0.7053660038532718;[TGM2]
GO:0006884;cell volume homeostasis;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;49.534292112730455;6.444869117505266;0.0016578681790444336;0.6527112189764278;[SLC12A2, SLC12A1, AQP1, SHANK3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[ALAS2, TFRC, ABCB6, SLC40A1, HEPH, HMOX1, SLC11A1, CYBRD1, TF, LCN2, LTF, ABCG2]
GO:0006638;neutral lipid metabolic process;5.0;0.7140352122741334;0.6472586179979869;8.874752450115741;40.65859522084085;5.266214121163619;0.0013608065916814918;0.5595554469212292;[SLC22A4, MOGAT2, ABHD12, NKX2-3, SNCA, DGAT2, GPX1, ACSL1, CAV1, DGKZ, SIRT1, FABP1, FABP7]
GO:0033214;iron assimilation by chelation and transport;12.0;1.0;0.9481203125901445;9.628524252492122;187.8365459949287;9.777073627680469;0.006286720152533999;0.9481203125901445;[LTF]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, E2F1, HMOX1, FABP1, BCL2]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, RORA, BRCA1, PTGS2, SULF1, SULF2, C3, IL1A, IL1B, C3AR1, CYP1B1, HPSE, NOX1]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, HPSE, GATA1, CYR61, LTF, CTHRC1]
GO:2000296;negative regulation of hydrogen peroxide catabolic process;8.0;1.0;0.875;9.628524252492122;566.6184905972214;9.083926447120524;0.0189642109567545;0.839552420951524;[HP]
GO:0030185;nitric oxide transport;5.0;1.0;0.7902410118609202;9.628524252492122;43.442191728354636;8.67846133901236;0.0014539710617137646;0.7340579283277371;[EDN1, AQP1]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, ADAM8, TRIB1, NEDD4L, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, DAB2, CCDC22, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144B, IFNG, IL1B, DTL, CEBPA, LRP1, LRP2, IL33, EGF, PSMC6, NEDD4, PSMC2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, SYNJ1, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, IL18, PYCARD, IL23A, CD24, IL12RB1, IL6R, ICOSLG]
GO:1900229;negative regulation of single-species biofilm formation in or on host organism;6.0;1.0;0.8231203125901445;9.628524252492122;121.420081227941;9.083926447120524;0.004063820847720553;0.7876727335416686;[LTF]
GO:0032913;negative regulation of transforming growth factor beta3 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.63944001314535;9.777073627680469;0.002866274986747803;0.8509193652572005;[CD24]
GO:0001878;response to yeast;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;28.654098265158677;8.390779266560578;9.59026881920657E-4;0.7522251544931926;[PTX3, MPO, ELANE]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[IGFBP5, PTAFR, AQP9, SLC8A1, AQP1, KCNQ1, NOX4, SLC26A3, CFTR]
GO:0032597;B cell receptor transport into membrane raft;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;336.41565742558566;9.777073627680469;0.011259529299599152;0.9324289523296623;[CD24]
GO:0033326;cerebrospinal fluid secretion;6.0;1.0;0.8231203125901445;9.628524252492122;48.40223855199413;8.67846133901236;0.0016199793651486486;0.7669372290569613;[AQP1]
GO:0051612;negative regulation of serotonin uptake;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;189.71062538080213;8.67846133901236;0.006349443903017236;0.8188169164668168;[SNCA]
GO:0006182;cGMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;6.558197802812269;0.20510234751766956;0.7678154929528684;[GUCY2C, ADCY9, AQP1]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0060586;multicellular organismal iron ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;58.33118610341119;7.57984905034425;0.0019522923042219213;0.8028748447945538;[SLC11A1, SLC40A1, RHAG]
GO:0015695;organic cation transport;6.0;0.6260725219892441;0.6361565735847665;8.077926840080956;30.14448825076878;6.063501560976162;0.0010089088934751224;0.6332080644001243;[SLC22A4, SLC44A5, SLC44A1, ABCB4, SLC22A2, PDZK1, SLC5A7, SLC7A8, RHAG, RHCE]
GO:0070947;neutrophil mediated killing of fungus;9.0;1.0;0.896240625180289;9.628524252492122;160.9383427215967;9.777073627680469;0.005386461495786884;0.896240625180289;[ELANE]
GO:1903861;positive regulation of dendrite extension;10.0;1.0;0.9152410118609203;9.628524252492122;830.9775978573329;6.832634648514029;0.027812072369000178;0.7646622655359331;[SYT2, CPNE5, NEDD4L]
GO:0032471;negative regulation of endoplasmic reticulum calcium ion concentration;11.0;0.9326813400603323;0.8987696223598284;9.57973408832269;289.7905246169981;7.697632086000634;0.009699028064390986;0.8260862151842345;[TGM2]
GO:1903988;ferrous iron export across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;235.30956556831262;9.777073627680469;0.007875599394711351;0.9324289523296623;[SLC40A1]
GO:1904715;negative regulation of chaperone-mediated autophagy;8.0;1.0;0.875;9.628524252492122;775.6380740464814;8.67846133901236;0.025959908309388966;0.8188169164668168;[SNCA]
GO:0045987;positive regulation of smooth muscle contraction;8.0;0.7671156992804218;0.7585578496402109;9.081980546124052;66.30038010178355;6.280566066213989;0.002219014055538479;0.6961884407023742;[GHSR, MYOCD, EDN1, PTAFR, F2R, TACR3, PTGS2, KIT, PROK2]
GO:0071472;cellular response to salt stress;6.0;0.7763722522362496;0.7113064387082693;9.34084218004034;100.19865821471498;7.57984905034425;0.0033535589175086402;0.710754145523778;[ABCB4, AQP1]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[ABCB4, SLC22A2, SLC1A3, SLC7A11, LRP2, SLC1A6, AQP1, SLC17A6, SLC17A3, SLC19A2, ABCC3, ABCA8, RHAG, ABCG2]
GO:0002812;biosynthetic process of antibacterial peptides active against Gram-negative bacteria;9.0;1.0;0.896240625180289;9.628524252492122;215.433854396427;9.777073627680469;0.007210377228767073;0.896240625180289;[ELANE]
GO:0045079;negative regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;841.3347014012318;8.67846133901236;0.02815871530382644;0.8188169164668168;[IL6, ELANE]
GO:0071474;cellular hyperosmotic response;6.0;0.8933024483968273;0.7697715367885581;9.548481544818586;99.28236748284083;7.379178354882098;0.003322891491320933;0.7004918368257019;[ABCB4, AQP1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4]
GO:0050778;positive regulation of immune response;5.0;0.46069491669276497;0.5205884702073027;6.7568446276081096;78.39406295848602;3.1543373037306295;0.002623778737144363;0.45155396826539046;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, PRKACB, MED1, MEF2C, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, C2, C3, KLRK1, C7, PLCG2, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, HLA-DRB4, FZD5, HLA-DRB1, DENND1B, ITK, IFIH1, CTLA4, HLA-DPA1, HAVCR2, ANXA1, RIPK2, NFAM1, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, CARD9, NR1H4, HLA-DPB1, TNF, CLU, PYCARD, IGHG1, GRAP2, CD177, LAG3, CD180, MSH6, CLEC4A, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, PTPN22, TNFSF13B, FCGR3A, CR2, CR1, CHUK, LCK, XCL1, LCP2, PIK3C3, C1S, UNC93B1, C1R, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, ICAM2, ICAM3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, CD14, PAG1, SH2D1A, TNFSF13, PTK2, MARCO, CD28, IGHM, CD40, CD3G, CD3E, CD3D, CTSS, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CCR2, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, HCK, IL1B, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, RELB, PAK1, IGKC, CD74, IL33, LILRB1, MLH1, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, THEMIS, MUC3B, CARD11, C5AR1, DDX60, RASGRP1, STAP1, NLRP3, BTNL8, TGFB2, TGFB1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0070945;neutrophil mediated killing of gram-negative bacterium;10.0;1.0;0.9152410118609203;9.628524252492122;161.63148990215663;8.67846133901236;0.005409660508128262;0.8590579283277371;[ELANE]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[IFITM1, IFIT1, TNF, OASL, CCL5, RSAD2, EIF2AK2, ISG15, PLSCR1, SLPI, OAS1, OAS3, APOBEC3A, LTF]
GO:0098915;membrane repolarization during ventricular cardiac muscle cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;124.80295429285788;7.697632086000634;0.00417704256481522;0.7898978880348613;[KCNH2, KCNQ1]
GO:0051622;negative regulation of norepinephrine uptake;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;44.494875090957315;9.777073627680469;0.0014892034265065574;0.8231203125901445;[SNCA]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[TNFAIP3, NEDD4L, RNF6, ZNRF1, UBE2Q2, HACE1, UBE2C, CDC34]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, IRF8, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, STAT1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0030163;protein catabolic process;5.0;0.6347111282356054;0.607596575978723;8.35223078658656;135.66522553384723;3.7109655375767217;0.004540593007841691;0.48001996203013964;[, CDC20, AKT1, TRIM25, SKP2, CDC34, NEDD4L, ADAMTS12, ELANE, PLK1, CTSD, SIRT1, PSMA5, PSMA6, CEACAM1, PSMA3, PSMA4, PSMA2, PCNP, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, ABHD12, LAMP2, AP2M1, PSMD14, UBR1, CCNB1, WFS1, UBE2C, CDK1, HPSE, ARRB1, ARRB2, BIRC2, DENND3, RNF6, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:1902303;negative regulation of potassium ion export;10.0;0.9326813400603323;0.8815816818910864;9.585964638073326;415.33946388596297;9.083926447120524;0.013901038075013616;0.8797934328124444;[KCNH2, KCNE3]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[UHRF1, NEDD4L, BMI1, TRIM25, DTL]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, CDC34, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0006873;cellular ion homeostasis;6.0;0.5537205960740763;0.5999806106271827;7.731404267606241;50.27869860014408;3.370193641611155;0.0016827827942558242;0.49547217215217104;[TFRC, SLC4A1, SLC4A3, EDNRA, EDNRB, C3AR1, PROK2, PTGDR, SLC11A1, PRKCE, AGTR1, CFTR, ABCB6, FPR1, NEDD4L, FPR3, FPR2, THY1, PKHD1, C7, CD19, PLCG2, HMOX1, PLCG1, ELANE, CCR10, CCR1, TF, CALM3, CD24, GPR18, NOX1, CD40, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, CD52, EDN1, GPR35, AVPR1A, IL1B, CCL13, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, CXCR1, CXCR3, CXCR2, CCL19, GPR157, CCL23, CCL21, SLC31A2, TMEM64, GPR6, XK, FKBP1B, F2RL1, RHAG, GRINA, F2RL3, CXCL13, SLC8A1, CCRL2, SLC26A11, TGM2, PDGFRA, F2R, ATP1B2, ATP1B1, ADCYAP1, ABCG2, CALCA, C5AR1, ITPR3, HRH4, DRD4, TGFB1, WFS1, VDR, CAV1, CYBRD1, CXCL10, CXCL11, CXCL12, PTPRC, DMXL2, LCN2, SLC26A8, BCL2, SLC26A7, CCDC22, SLC26A3, CXCL9, ALAS2, LRRK2, ATP2A3, SLC40A1, FASLG, GRM5, ATP7B, HEPH, CA2, TRPC7, PTGIR, TRPC3, TRPC1, LCK, XCL1, LTF, CX3CR1, SLC24A2, SLC24A1, SLC24A4, CAMK2D, ATP2C2, GNA15, CCL8, PLN, CCL7, SV2A, P2RY2, CCL5, S1PR3, CCL1, SNCA, PML, SLC4A7, P2RX5, CD4]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[, SCARB2, ACSM5, CYP1B1, ACSL1, ACSL5, MIF, POR, SLC27A3, SLC27A2, MGST1, ALOX12, ACAT1, C3, PRKAR2B, CYP4F2, CYP4F3, CYP4F12, FA2H, TBXAS1, TECR, ACSM2A, ETFA, BRCA1, GHR, ACADM, HIBCH, EDN1, GPX1, ELOVL4, CYP4A11, ELOVL6, ELOVL7, NDUFS6, EHHADH, ACSBG1, HSD17B4, AOAH, PTGS2, CYP3A4, PTGS1, ALOX5, SNCA, CD74, PNPLA8, MAPK14, SCD, NDUFAB1, PLP1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, TGM2, PDGFRA, PRKCE, F2R, ATP1B1, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, PKHD1, CD19, HRH4, PLCG2, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, VDR, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, BCL2, CALM3, CD24, GPR18, CXCL9, CD40, ATP2A3, FASLG, ADM, GRM5, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, TRPC7, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, CAMK2D, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, GNA15, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL23, CCL21, TMEM64, GPR6, PML, P2RX5, CD4, XK, FKBP1B, F2RL1, GRINA, F2RL3]
GO:0044793;negative regulation by host of viral process;7.0;0.8653626801206646;0.7836007053175329;9.456673995565463;73.7499023337935;7.57984905034425;0.0024683428605091124;0.738553198190834;[PTX3, LTF]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, F2RL1, TEK]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, NEDD4L, GATA3, ADAMTS12, CFP, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, RIPK2, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, UBR1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ARRB1, ARRB2, SCPEP1, ADAMTS1, ADAMTS20, ASPH, MEP1A, PIK3C3, DTL, BIRC2, BIRC3, C1S, C1R, UHRF1, HM13, VPS4B, FGL2, ZNRF1, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CDC20, ANPEP, TRIM25, SKP2, ASRGL1, CDC34, CFTR, CTSZ, CTSW, BRCA1, PCSK6, PCSK5, CTSS, CTSH, CTSG, CTSD, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, PCNP, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, GGH, ISG15, NFKBIA, UBA3, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, RNF6, USP18, AURKB, TBX21, NRIP3, TNIP3, CPVL, RBMX]
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;238.42697029648212;8.67846133901236;0.007979936125481077;0.8188169164668168;[STMN1, SNCA]
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;6.0;1.0;0.8231203125901445;9.628524252492122;64.1120899346335;7.212124270218933;0.002145773952977257;0.6919486831672181;[AQP1]
GO:0030157;pancreatic juice secretion;6.0;1.0;0.8231203125901445;9.628524252492122;60.48885175748684;7.8311634786251565;0.0020245074318908153;0.7236063770733796;[AQP1]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, PDGFA, IQGAP3, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, NOX4, CALM3, CD24, EZH2, CD40, MAP4K1, EDN1, SYK, RIPK2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CD40LG, PKN1, CAMK1, CCNT2, TNF, MAP3K8, PDGFRB, MAP2K2, F2R, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, DRD4, MAP2K6, TGFB1, GH1, BMP2, CDK1, CSPG4, LRRK2, ARRB1, GHR, PSRC1, IFNG, PDE5A, LTF, NOD2, THBS1, CSK, SNCA, EGF, MAPK14]
GO:0042416;dopamine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;507.8534772351106;7.474488534686424;0.01699739884460309;0.7572456912631272;[NR4A2, TGFB2, GPR37, GCH1, SNCA]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, ARRB1, ARRB2, TNF, CLU, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, GREM1, SFRP4, IL1B, DOCK2, NLGN1, CD151, LRP1, NEDD4L, DLL1, C2, RAB21, C3, NTF3, PLCG2, STAP1, CCL2, NCKAP1L, CCL19, CD14, SNCA, CCL21, EGF, AZU1, SELE, TF, DAB2, SYNJ1, F2RL1, PTX3, FCGR2B]
GO:0042775;mitochondrial ATP synthesis coupled electron transport;7.0;1.0;0.8509193652572005;9.628524252492122;33.34232067890278;7.57984905034425;0.0011159374669824286;0.738553198190834;[NDUFB6, SNCA]
GO:1902957;negative regulation of mitochondrial electron transport, NADH to ubiquinone;13.0;1.0;0.9625549647676366;9.628524252492122;1582.933473614211;9.777073627680469;0.052979358814230854;0.9625549647676366;[SNCA]
GO:0045920;negative regulation of exocytosis;8.0;0.7140352122741334;0.7320176061370667;9.004369943419128;172.2069348332117;6.375876246018314;0.005763611132688151;0.701062607729944;[ANXA1, FMR1, VPS4B, GNAI2, RAB33B, CEACAM1, HMOX1, FCGR2B, IL13RA2, CCR2, SNCA]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;292.0931097099921;6.139487467954083;0.009776093515261451;0.7620939872166814;[CALCA, EDN1, GPR35, F2R, GNA15, C3AR1, AGTR1, F2RL1, GPR18, GPR157, F2RL3, TGM2]
GO:2001288;positive regulation of caveolin-mediated endocytosis;8.0;1.0;0.875;9.628524252492122;174.0741500880123;9.083926447120524;0.005826105146881698;0.839552420951524;[NEDD4L]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[SLC4A1, SLC4A3, AQP1, BEST1, SLC4A7, CA2, CA4, SLC26A8, SLC26A7, SLC26A11, RHAG, SLC26A3, CFTR]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0032600;chemokine receptor transport out of membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;247.9928586842006;9.777073627680469;0.008300097801077391;0.9324289523296623;[CD24]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:0042789;mRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;1288.3918881325048;6.832634648514029;0.043121317018375266;0.781850206004675;[MED1, C5AR1, LMO2, FLNA]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A1, SLC4A3, PHB2, AQP1, SCN1A, SLC6A16, SLC11A1, SLC6A15, PRKCE, CACNA2D3, SLC6A13, SLC6A12, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, TTYH3, TTYH2, SLC22A2, ATP5J, NEDD4L, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, PLCG2, KCNN3, SCN3A, ABCA1, SLC6A6, FXYD2, SFXN3, FXYD6, NOX1, GABRB1, COX7B, CLIC3, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, SLC7A9, CLDN17, SGK1, CAPS2, SLC43A2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A1, SLC17A3, CCL21, SLC31A2, GABRA5, COX6C, FKBP1B, RHAG, KCNG2, STEAP3, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, BEST1, SLC26A11, SLC16A3, KCNH1, KCNH2, CHRNB4, SLC38A1, F2R, ATP11C, CYBB, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, ITPR3, CACNA1F, SLC1A6, SLC38A6, CYC1, SLC15A3, CLCA4, GRIA4, ATP8B2, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, ASPH, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC5A10, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNIP4, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, TGM2, FCER1G, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, TGM2, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0003064;regulation of heart rate by hormone;9.0;1.0;0.896240625180289;9.628524252492122;30.04555666387609;9.083926447120524;0.0010055977422944718;0.8607930461318132;[KCNH2]
GO:0042541;hemoglobin biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;238.03201882828247;8.16763571524637;0.007966717455273678;0.7408135829017477;[ALAS2, INHBA]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, GNLY, S100A12, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, S100A9, LTF, PF4]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, FFAR2, ADAM8, CCR6, SELE, S100A9, ELANE, S100A8, JAM3]
GO:0002768;immune response-regulating cell surface receptor signaling pathway;6.0;0.6835726970475526;0.6649066611139208;8.807543700422292;76.39633531366081;3.743987405881668;0.0025569165907102184;0.5145880026401528;[, CYFIP1, CLEC10A, ICAM2, ICAM3, SLA2, TRBC1, C3AR1, PRKACB, ICOSLG, MEF2C, PRKCB, PRKCE, PRKCD, HLA-G, BTK, PRKCQ, HHLA2, TXK, FPR1, FPR3, FPR2, GATA3, THY1, CD79B, CD79A, KLRK1, CD19, INPP5D, PLCG2, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, PAG1, LYN, JUN, HLA-DRB4, PTK2, CD28, CD24, HLA-DRB1, IGHM, DENND1B, ITK, CD40, CD3G, CD3E, CD3D, FCER1A, CTLA4, MUC13, CD38, FFAR2, MUC15, HLA-DPA1, FCER1G, SYK, RIPK2, FOS, GAB2, LIME1, VAV1, LAT2, HCK, KIT, IGHD, HLA-DQB1, LILRA2, RELB, PAK1, NRAS, IGKC, CARD9, LILRB1, LILRB2, HLA-DPB1, FCN1, TRAC, IGHG1, FCGRT, GRAP2, THEMIS, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11, BLK, C5AR1, KIR2DL1, IGLV1-44, BTNL8, EIF2B3, BMX, NFKB1, PTPRC, NR4A3, BCL2, HLA-DRA, NFKBID, IGKV3-20, LAT, PIK3CD, PTPN22, FCGR3A, PDE4B, CR2, CR1, CHUK, PDE4D, FGR, ZAP70, LCK, LCP2, CLEC12B, FYN, CSK, FCGR1A, FCGR1B, TRAT1, CD4, FCGR2A, PTPN6, MNDA, CD247, FCGR2B]
GO:2000768;positive regulation of nephron tubule epithelial cell differentiation;8.0;1.0;0.875;9.628524252492122;415.05780765516636;8.67846133901236;0.013891611294443005;0.8188169164668168;[CD24]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, SRPX, CDKN1A, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, HP, TNF, CLU, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, ITGAM, PLEKHF1, LRRK2, ITGB2, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, GZMA, GZMB, PML, P2RX1, MNDA, FCGR2B, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, EGR1, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, IL10, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, ARRB1, ARRB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, SYNJ1, NEDD4, CD9, RAMP1]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, MAP3K8, PDGFRB, MAP2K2, F2R, MIF, ADAM9, ADAM8, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, RASGRP1, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, GADD45B, FZD8, EIF2AK2, GH1, BMP2, CDK1, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, ARRB1, GHR, MAP4K1, EDN1, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0014048;regulation of glutamate secretion;8.0;0.811012628672052;0.780506314336026;9.485423408851448;84.2585196773718;6.8867018697843045;0.0028200568258570785;0.7271862538851576;[IL1RN, IL1B, AVPR1A, KMO, SNCA]
GO:0055075;potassium ion homeostasis;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;71.74727346628734;6.409777797693995;0.0024013166745626502;0.7027963346592216;[SLC12A2, KCNH2, SLC12A1, KCNA5, ATP1B2, ATP1B1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0006783;heme biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.464221201200845;646.2085211808783;6.781341354126479;0.02162801765401235;0.6977174774718518;[ALAS2, FECH, CPOX, PPOX, ALAD, UROD, HMBS]
GO:1902732;positive regulation of chondrocyte proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;46.85374737656315;8.67846133901236;0.0015681527590585545;0.7669372290569613;[LTF]
GO:0060306;regulation of membrane repolarization;7.0;0.7090535922965819;0.7054461614054914;9.158520623246385;46.46513856105386;6.311337724880743;0.0015551463717286865;0.6736814700148209;[KCNH2, KCNE3, KCNQ1, CAV1, FLNA, NEDD4L, KCNA5]
GO:0060307;regulation of ventricular cardiac muscle cell membrane repolarization;9.0;0.811012628672052;0.801746939516315;9.474373572664863;48.25689803028158;6.781341354126479;0.001615114948684907;0.7430387373949403;[KCNH2, KCNE3, KCNQ1]
GO:0006782;protoporphyrinogen IX biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.5544162803384;624.2719366194988;7.697632086000634;0.020893819910387346;0.7445766281117727;[ALAD, ALAS2, UROD, HMBS, CPOX, PPOX]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, STAT1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0006779;porphyrin-containing compound biosynthetic process;6.0;0.7043150770688792;0.675277851124584;9.195660170195843;516.3558939044244;6.641579411751319;0.01728196707884681;0.6627709925721352;[ALAS2, ABCB6, FECH, CPOX, PPOX, ALAD, UROD, HMBS]
GO:2000650;negative regulation of sodium ion transmembrane transporter activity;10.0;0.8259837884571596;0.8282329060895002;9.464221201200845;676.2962608223798;7.292166977892469;0.02263502722260573;0.7881627702307852;[CAMK2D, PRKCE, NEDD4, NEDD4L]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, PDE4D, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, NFKBID, LAT, HLA-DRB1]
GO:0014059;regulation of dopamine secretion;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;80.46310298086182;6.444869117505266;0.0026930276446781535;0.7045909063862833;[CXCL12, CNR1, SNCA]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0085018;maintenance of symbiont-containing vacuole by host;6.0;1.0;0.8231203125901445;9.628524252492122;26.843536284103255;9.777073627680469;8.984290018147254E-4;0.8231203125901445;[AQP1]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, TRPC1, F2R, THY1, CXCL10, CXCL11, JPH2, CD19, XCL1, CALM3, PLCG1, F2RL3, SNCA]
GO:2000308;negative regulation of tumor necrosis factor (ligand) superfamily member 11 production;7.0;1.0;0.8509193652572005;9.628524252492122;85.23397490503757;9.777073627680469;0.002852704434474342;0.8509193652572005;[LTF]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0002506;polysaccharide assembly with MHC class II protein complex;6.0;1.0;0.8231203125901445;9.628524252492122;58.63041707748974;9.083926447120524;0.0019623072956339374;0.7876727335416686;[HLA-DRA, HLA-DRB1]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, PDE4D, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, PF4]
GO:0033344;cholesterol efflux;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.599019797332524;0.001326765671179004;0.712474179321389;[ABCA1, NPC2, ABCG2]
GO:0019731;antibacterial humoral response;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;115.72816977122699;6.221725566191056;0.0038733176936520722;0.6690987000520388;[IGHM, DEFA4, HIST1H2BK, RNASE6, RNASE3, DEFA1, HLA-E, SLPI, CTSG, IGHA1, IGKV3-20, CAMP, LTF]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[IGHM, CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CLU, CXCL5, GNLY, S100A12, CTSG, IGHA1, PRSS3, ELANE, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, PPBP, LYZ, HLA-E, CXCL10, CXCL11, SLPI, BCL3, LCN2, PRTN3, BPI, S100A9, IGKV3-20, S100A8, LTF, PF4]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[TGFB1, FECH, ARG1, ABCB4, FOXO1, AQP1, ICAM1, RPS6KB1]
GO:0019732;antifungal humoral response;7.0;1.0;0.8509193652572005;9.628524252492122;115.32270466312094;8.16763571524637;0.0038597471413786694;0.7686126355688037;[DEFA4, LTF]
GO:1901381;positive regulation of potassium ion transmembrane transport;9.0;0.7369933605727446;0.7647373054666613;9.271849308553389;341.4877247401287;6.311337724880743;0.01142928682805268;0.7190027299379095;[KCNH2, KCNQ1, FLNA, ATP1B2, ATP1B1, DNM2]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, CYP4F2, CYP4A11, CYP4F12, AQP1, ADCY9, PRKAR1B, PRKAR2B, PRKACB]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[GABRB1, TTYH3, CLIC3, TTYH2, SLC1A3, SLC4A1, BEST1, SLC26A11, GABRE, CLCA4, SLC12A2, GABRA5, SLC12A1, CLDN4, SLC26A8, SLC26A7, CLDN17, SLC26A3, CFTR]
GO:0034395;regulation of transcription from RNA polymerase II promoter in response to iron;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;252.6466751378032;9.083926447120524;0.00845585684961658;0.8969813732811862;[SLC40A1, HMOX1]
GO:0003097;renal water transport;6.0;0.8933024483968273;0.7697715367885581;9.523163736834295;25.336377220787078;8.16763571524637;8.479857443206279E-4;0.7408135829017477;[AQP1]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, MAP3K8, KCNH1, MEN1, PDGFRB, MEF2A, KCNH2, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, PAK1, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0046415;urate metabolic process;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;153.84051102177276;7.212124270218933;0.005148903456427586;0.659069382437994;[SLC17A1, SLC17A3, ABCG2, SLC22A11]
GO:0032769;negative regulation of monooxygenase activity;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;96.37597526722934;7.379178354882098;0.003225617159447592;0.7004918368257019;[CNR1, CAV1, GFI1, NFKB1, SNCA]
GO:0051561;positive regulation of mitochondrial calcium ion concentration;11.0;1.0;0.9324289523296623;9.628524252492122;289.38505950888515;7.474488534686424;0.009685457512117352;0.8146746435927894;[TGM2]
GO:0002438;acute inflammatory response to antigenic stimulus;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;43.66651068845287;7.57984905034425;0.0014614788154342952;0.710754145523778;[CD6, CXCR2, GATA3, ELANE, ICAM1]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[ITGAM, LRRK2, ITGB2, RORA, THBS1, HSPD1, STAP1, HAVCR2, SNCA, IL10, CD74, IL33, MIF, BPI, TLR6, FCGR2B, TLR4, CD200]
GO:0048169;regulation of long-term neuronal synaptic plasticity;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;42.75619717690252;6.481236761676141;0.0014310114414316764;0.7276913745807394;[GRM5, KIT, EPHB2, SHANK3, SNCA]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CCNA2, FOXO1, DNM2, AQP1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, RNF43, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, TCF7, GATA3, APCDD1, PLCG2, FZD1, FZD5, FZD8, NR4A2, VANGL1, DAB2, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, ARRB2, HHEX, AXIN2, AES, PLCB1, LEF1, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A2, SLC24A1, NLGN1, PLK2, ITPR3, PRKCZ, TNR, SHANK3, SNCA]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0034145;positive regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.474488534686424;0.01691115913508416;0.7784863164434164;[F2RL1, PTPN22, LTF]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[LRP1, ITGB3, MARCO, RARA, CD36, TGM2]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:1904307;response to desipramine;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;62.210167333483;9.777073627680469;0.0020821183151359633;0.7902410118609202;[SNCA]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CDC20, TRIM25, SKP2, CDC34, NEDD4L, PLK1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PCNP, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PSMD14, UBR1, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, BIRC2, RNF6, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[LRRK2, FASLG, SLC4A1, SLC4A3, CA2, SLC26A11, SLC11A1, AVPR1A, SLC4A7, DMXL2, SLC26A8, BCL2, SLC26A7, SLC26A3, CFTR, NOX1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, LTB4R, ADCYAP1, NPY, PNOC, PROK2, GPR19]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, IKZF1, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, TAL1, KIT, ACIN1, HCLS1, TRIM10]
GO:0071288;cellular response to mercury ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;9.083926447120524;0.002604253811492351;0.7876727335416686;[AQP1]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, IRF8, CTSG, CD36, TNF, MPO, ELANE]
GO:0072139;glomerular parietal epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;51.0109489693332;9.083926447120524;0.0017072905551300363;0.8154717862087246;[CD24]
GO:0050922;negative regulation of chemotaxis;6.0;0.6467165523344657;0.6464785887573774;8.415501612646269;97.5406619249953;5.8067817141283475;0.0032645981737330788;0.6200793994936333;[ROBO2, NRP1, SEMA5B, CXCL13, THBS1, AIF1, KLRK1, MMP28, STAP1, CCL2, ELANE, SEMA4A, SEMA6A, SEMA4B, MIF, GREM1, PADI2, GPR18]
GO:0031665;negative regulation of lipopolysaccharide-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;344.71221365858594;7.212124270218933;0.011537207570301822;0.7197477358342742;[TNFAIP3, TRIB1, LILRA2, LTF]
GO:0038178;complement component C5a signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;245.7153283963706;9.083926447120524;0.008223870911987907;0.8797934328124444;[C5AR1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0051585;negative regulation of dopamine uptake involved in synaptic transmission;9.0;0.9326813400603323;0.8625812952104552;9.601125278304007;543.5031361224321;9.777073627680469;0.01819056084495172;0.896240625180289;[SNCA]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C1QB, C1QA, CFH, C1S, C1R, PROS1, C5AR1, CFI, CFP, CLU, C2, C3, IGHG1, IGKC, C7, CD19, IGLV1-44, C3AR1, A2M, CR2, CR1, SERPING1, IGKV3-20, CFB, C1QC]
GO:0051583;dopamine uptake involved in synaptic transmission;9.0;1.0;0.896240625180289;9.628524252492122;254.03495274861447;7.9853141584524145;0.0085023212518817;0.8046099625986299;[SNCA]
GO:0071872;cellular response to epinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;7.212124270218933;0.01373211325256535;0.7438283705770736;[KCNQ1, PDE4D, PDE4B, SNCA]
GO:0050812;regulation of acyl-CoA biosynthetic process;7.0;0.8436909121759173;0.7727648213451592;9.466005322994347;197.71914732637842;7.57984905034425;0.006617481925333854;0.738553198190834;[SNCA]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, ETS1, SLC8A1, AQP1, ICAM1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, CYBB, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, RIPK2, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, HDAC2, PCNA, PTAFR, NOD2, PTGS2, AIF1, GNAI1, CST3, CCL7, CTNNA1, FYN, KLF4, MAPK13, FABP1, RAD51, RPS6KB1, CD69]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1903238;positive regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;440.9461040801303;8.390779266560578;0.014758069277832396;0.8443458537639685;[ITGA4, PTAFR, ELANE, CCR2]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, CDCA3, PDGFA, GATA3, FN1, EIF2AK2, JAK3, DUSP2, DUSP3, DUSP1, BGN, DUSP6, NRAS, SPP1, IL12RB2, COL3A1, PKN1, SLA, EFEMP1, MAP3K8, KCNH1, KCNH2, CISH, FBXW2, CDC25A, BLK, PKMYT1, NAE1, NEK7, BMX, SPTB, UHRF1, HM13, IL2RG, ZNRF1, EIF4H, FYN, IL2RB, EIF3F, CDC20, HERC5, C1GALT1C1, LGALS1, TNFSF11, TRIM25, SNRPD3, ALG8, BTC, CDC34, BTK, TRIB1, NAIP, EPB42, SDC2, GSPT1, EGR2, PTK2, MUC13, MUC15, SPTAN1, SYK, IL18, RNF144B, IL1B, KIT, PCNA, PCNP, IL33, KITLG, NDUFAB1, BUB1B, LOXL1, LOXL2, TGM2, MUC3B, UBE2C, NAT8, UBA3, UBE2M, FBN1, TNFAIP3, GHR, CAD, IRAK3, SHANK3, RNF6, SPOCK3, TNIP3, TEK, PRKCH, PRKCB, PRKCE, PRKCD, HMBS, PRKCQ, PRKCZ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, PLK1, BTG2, ASGR1, ASGR2, IFIH1, TIMP1, CIT, RARA, USP1, GSN, NR1H4, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, UBR1, MAP2K6, COPS5, P4HA2, BCL2, CCDC22, LAT, GAL3ST1, CYR61, TLK1, LCK, HDAC2, TPTE, DENND3, NLRC4, NOD2, TTR, CSK, PML, CPPED1, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, TXK, LIF, PRL, STRADB, GFRA3, PARP9, ZDHHC17, HCK, TLR7, TLR4, TLR2, GUCY2C, CSTA, CST3, APBB1, QPCT, LOX, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, LEF1, THBS1, BUB1, SNCA, WEE1, RPS6KB1, EHMT2, MYLK, KRTCAP2, PSMD3, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, THY1, IQGAP3, C3, LYN, ABCA1, HACE1, LYZ, BHMT, EZH2, RIPK2, ACTL6A, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FSTL1, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A9, S100A8, FOXO1, SOCS2, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, PIK3CD, ARRB1, ARRB2, UTY, DSP, PPP1R12A, BIRC5, PIK3C3, DTL, BIRC2, BIRC3, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, PTPN7, PTPN4, CCNH, CCNC, EPHB2, EPHB1, PAQR3, EREG, MXRA8, ALPK2, EPHA3, EPHA2, TF, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, BMI1, PCSK5, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, NEDD4, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP1, RASGRP4, FUT4, FUT3, SPTA1, CCNB1, FUT7, ISG15, CLK4, CLK1, IL6, BMP2, LAMC1, UBE2Q2, MMP1, DDX58, MMP2, CCNA2, VCAN, TAF9, AURKB, GALNT7, GALNT6, EGF, LAMB1, MAPK14, MAPK13, TAF5, NAA15, MED1, DAPK1, NEDD4L, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, RNF130, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, RNF43, IGFBP5, IGFBP3, MELK, CSF1R, CUL5, RASAL2, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, CDK6, CDK1, PTPN22, DUSP10, GPX1, CHUK, ASPH, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, FAM20C, SGK1, RANBP2, CAMK4, CAMK1, GALNT14, ARID4A, ARID4B, FBL, APLP2, MATK, CSF2RB, ADRB2, DTX3, CSF2RA, TGFB2, TGFB1, NFKBIA, FES, TGFBI, TGFBR3, FGR, EHHADH, CAMK2D, USP18, NCAM1]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[CHRM2, LHCGR, CHRM1, C5AR1, F2R, FPR1, FPR3, FPR2, GPR84, NMBR, LTB4R, MC3R, GRM5, P2RY6, GNA15, EDNRB, P2RY2, GNAQ, CXCR2, C3AR1, AGTR1, F2RL3]
GO:0002430;complement receptor mediated signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.57973408832269;218.73839564357212;7.212124270218933;0.007320977250414979;0.7650689957573628;[CR2, CR1, C5AR1, FPR1, C3AR1, FPR3, FPR2]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[LHCGR, PTAFR, CD244, SNCA]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, TGM2, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG2, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL1, F2RL3]
GO:0051354;negative regulation of oxidoreductase activity;5.0;0.6913464685778243;0.6359142461498324;8.625222143628337;69.01231522542857;6.599019797332524;0.0023097800835437223;0.6277151911823093;[LRRK2, CAV1, GZMA, GFI1, HP, NFKB1, CNR1, SNCA]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, TGM2, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, IRF8, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, MARCO]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[NCF1, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, CYBB, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, GPX2, ANXA1, GPX1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, HDAC2, PCNA, AIF1, CST3, SNCA, KLF4, SOD2, MAPK13, FABP1]
